Predicting bleeding risk in NSTEMI

In this large derivation and validation cohort (from the CRUSADE quality improvement initiative), researchers developed a risk score to predict the risk of major in-hospital bleeding in patients with NSTEMI. This can be easily calculated at the following url (link), and can be used to make decisions on risk / benefit ratios of various anticoagulant medications for NSTEMI patients.

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment